Nemorubicin
Get a Quick Quote Now
Select Packaging
Product Description
Product
Nemorubicin
CAS
108852-90-0
Formula
C32H37NO13
Synonym
Nemorubicin, 108852-90-0, Nemorubicin [INN], Methoxymorpholino-doxorubicin, Methoxymorpholinyl doxorubicin, FCE-23762, pnu 152243, CHEBI:42053, 7618O47BQM, PNU152243A, 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN, (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-((S)-2-methoxymorpholino)-alpha-L-lyxo-hexopyranoside, 3'-deamino-3'-(2-methoxymorpholin-4-yl)doxorubicin, methoxymorpholinoDX, (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside, Methoxymorpholinyldoxorubicin, DTXSID6057619, methoxymorpholinyl-doxorubicin, methoxy-morpholinyl-doxorubicin, UNII-7618O47BQM, Fce 23762, PNU-152243, SCHEMBL24646, NEMORUBICIN [WHO-DD], 3'-deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin, CHEMBL1232279, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-a-Llyxo- hexopyranosyl]oxy]-, (8S,10S)-, AMY10326, PNU-152243A, CS-2020, BP-29358, HY-15794, MS-30933, A14363, F84993, A855698, Q27120450, Methoxymorpholinyldoxorubicin; PNU 152243; PNU152243; PNU-152243; PNU-152243A, (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 2,3,6-TRIDEOXY-3-((S)-2-METHOXYMORPHOLINO)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE, (8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, 5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-((2S)-2-METHOXY-4-MORPHOLINYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, (8S,10S)-, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Nemorubicin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Nemorubicin
Product Description
Product
Nemorubicin
CAS
108852-90-0
Formula
C32H37NO13
Synonym
Nemorubicin, 108852-90-0, Nemorubicin [INN], Methoxymorpholino-doxorubicin, Methoxymorpholinyl doxorubicin, FCE-23762, pnu 152243, CHEBI:42053, 7618O47BQM, PNU152243A, 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN, (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-((S)-2-methoxymorpholino)-alpha-L-lyxo-hexopyranoside, 3'-deamino-3'-(2-methoxymorpholin-4-yl)doxorubicin, methoxymorpholinoDX, (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside, Methoxymorpholinyldoxorubicin, DTXSID6057619, methoxymorpholinyl-doxorubicin, methoxy-morpholinyl-doxorubicin, UNII-7618O47BQM, Fce 23762, PNU-152243, SCHEMBL24646, NEMORUBICIN [WHO-DD], 3'-deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin, CHEMBL1232279, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-a-Llyxo- hexopyranosyl]oxy]-, (8S,10S)-, AMY10326, PNU-152243A, CS-2020, BP-29358, HY-15794, MS-30933, A14363, F84993, A855698, Q27120450, Methoxymorpholinyldoxorubicin; PNU 152243; PNU152243; PNU-152243; PNU-152243A, (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 2,3,6-TRIDEOXY-3-((S)-2-METHOXYMORPHOLINO)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE, (8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, 5,12-NAPHTHACENEDIONE, 7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2,3,6-TRIDEOXY-3-((2S)-2-METHOXY-4-MORPHOLINYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, (8S,10S)-, 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Nemorubicin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
